INTRANASAL BLEEDING
Intranasal bleeding (« epistaxis ») affects close to 10% of worldwide population, i.e. 750 million patients (with 10% requiring medical attention).
Current treatments are ineffective in 30 to 50% of the patients.
CAVI-T : A SIGNIFICANT ADVANCEMENT THAT REINVENTS BALLOON TECHNOLOGIES
In the treatment of epistaxis, medical needs are not optimally addressed with current treatment options facing significant failure rates (30% to 50%) and often invasive. To fix this problem, Dianosic has developed and designed an Intranasal asymmetric balloon (CAVI-T), which addresses bleeding challenges while offering structural support post operatively.
CAVI-T ASYMMETRIC BALLOON
- Unique asymmetric design (low-pressure)
- Optimal conformation to the anatomy
- Easy to use / repositionable
- Anterior and posterior bleeding
- Nasal breathing through a dedicated channel
- Reduced pain and rebleeding upon removal
ASYMMETRIC BALLOON INSTRUCTION FOR USE
PROCEDURAL STEPS
PUBLICATIONS
An innovative solution in the management of bleeding and support of intranasal structures. Watch the video to learn more…
Bleeding arrest demonstrated in 90% of patients
Low pain upon removal
Ease of use
Patient comfort : breathing channel
Discreet, low pressure balloon
Quick return to home
Can be removed by a home nurse
Reduced budget impact (hospitals, insurers)